Safety profile of Trogarzo ® IV push similar to that of IV infusion New method of administration designed to make maintenance dosing easier for patients and health care providers and allow more ...
The new approval allows for the 2000mg loading dose to be administered as an IV push rather than a 30-minute IV infusion. The prescribing information for Trogarzo ® (ibalizumab-uiyk) has been updated ...
The approval was based on data from the phase 3 TMB-302 trial that evaluated Trogarzo 800mg administered via IV push once every 2 weeks. The Food and Drug Administration (FDA) has approved Trogarzo ® ...
(RTTNews) - Theratechnologies Inc. (THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, has received FDA approval for the intravenous push mode ...
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14, ...
JEFFERSON CITY — In Missouri, licensed practical nurses with the appropriate qualifications can now administer most IV push or bolus medications under the direction and supervision of a registered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback